Navigation Links
PolyRemedy Names Jeffrey Jones as Its Chief Operating Officer
Date:2/24/2009

MOUNTAIN VIEW, Calif., Feb. 24 /PRNewswire/ -- PolyRemedy, Inc., a manufacturer of point-of-care robotic systems for the fabrication and tracking of customized, nano-material-based wound treatments, has hired Jeffrey S. Jones to serve as the Company's chief operating officer (COO). Jones, a seasoned healthcare executive, joined the PolyRemedy management team in January 2009.

"With his experience in growing innovative medical device companies, Jeff brings a proven track record of driving change and achieving results in high growth environments," says Dan Eckert, president and chief executive officer of PolyRemedy. "With a national priority on reducing healthcare costs while improving the quality of care, the timing is great for us to introduce an evidence-driven wound care treatment system, and we are thrilled to have Jeff's experience and leadership on our team as we continue to build our company."

"PolyRemedy's expertise in providing customized wound treatments with objective wound care information is truly unique. We have a real opportunity to improve wound care outcomes," Jones says. "I look forward to working with everyone at PolyRemedy to deliver our innovative wound care treatment approach to the market." As COO, Jones is responsible for managing all aspects of PolyRemedy operations, including manufacturing, research and development, product engineering, software development, information technology, quality assurance, regulatory, materials, purchasing, customer and field service.

Prior to joining PolyRemedy, Jones served as COO at Reliant Technologies, a medical device company in Mountain View, Calif., that developed and launched the innovative Fraxel Laser for skin resurfacing. While there, Jones built strong operations, product engineering, regulatory, quality assurance and an in-house medical clinic to support product launches. By the time Reliant was acquired by Solta Medical in 2008, Jones had helped to grow the company revenue to an $88 million annual run rate.

Previously, Jones was COO at LuMend, Inc., Redwood City, Calif., an interventional cardiology medical device company and vice president of operations at EP Technologies, a subsidiary of Boston Scientific Corporation, San Jose, Calif., an interventional cardiology medical device company. Earlier in his career, Jones held various management positions, including director of Fiber Products Group at Coherent Inc., Palo Alto, Calif., a medical laser system company, and manager of Test and Test Engineering at Hughes Aircraft Company, Fullerton, Calif. Jones was also a captain in the U.S. Army.

Jones received a bachelor's degree in engineering from the United States Military Academy, West Point, NY, and an MBA from Golden Gate University, San Francisco.

About PolyRemedy

PolyRemedy, based in Mountain View, Calif., manufactures robotic systems for the fabrication of nano-fiber wound treatments, on demand and at the point of care. The innovative PolyRemedy system produces customized wound dressings within minutes, measured to fit the wound size and shape and fabricated with the precise material composition necessary to optimally treat the wound. The system also captures and monitors important wound treatment data with the potential to help evaluate costs, refine clinical protocols, and demonstrate evidence-based improvements in wound management.


'/>"/>
SOURCE PolyRemedy, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. PolyRemedy Hires Gary Coughlen as CFO
2. PolyRemedy Strengthens Executive Team With Additions of Diane Cooper, PhD, and Joe Coyne
3. Digirad Names Richard B. Slansky Chief Financial Officer
4. Cogdell Spencer Names Herritz and Wolters to Key Leadership Positions Within Erdman
5. Exagen Diagnostics Names John Alsobrook, Ph.D., Vice President and Chief Operating Officer
6. maxIT Healthcare Names David H. Tucker as National Accounts Business Director
7. Innerscope Research(TM) Names Caleb Siefert as Senior Scientist to Lead Companys Statistical Analyses and Study Designs
8. S.C.-Based Technology Consortium Names Interim Executive Director and Board
9. NHP Names New Chairman and Lead Independent Director
10. The SCAN Foundation Names New Members to Its Board
11. JNCCN Names New Publishing Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... Resoundant, Inc., ... invited to the Siemens Healthineers annual customer education symposium, a world-class learning conference ... place from March 27 - 31, 2017 at the Atlanta Marriott Marquis in ...
(Date:3/28/2017)... (PRWEB) , ... March 29, 2017 , ... ... by leading thyroid pharmacist Dr. Isabella Wentz, Pharm.D., FASCP. The program was recently ... it, besides answering common questions regarding thyroid function. , Dr. Izabella Wentz ...
(Date:3/28/2017)... WA (PRWEB) , ... March 28, 2017 , ... ... a 22% share of all holidays (IBT World Travel Trends Report). As travelers ... challenging, include a range in temperatures, and prolonged sun exposure. In response, the ...
(Date:3/28/2017)... Mateo, CA (PRWEB) , ... ... ... Society (RSS), a non-profit medical society dedicated to advancing the science and ... leveraging data from its RSSearch Patient Registry, a multi-institutional, observational registry established ...
(Date:3/28/2017)... ... March 28, 2017 , ... Alert Sentry Group LLC., a leader in ... Response Systems), the iSAFE and the iSAFE Plus. These iSAFE products are the most ... kind, the iSAFE and iSAFE Plus offer direct GPS Location and two-way calling with ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 29, 2017 Research and Markets has announced ... Software Market Outlook: 2016-2022" report to their offering. ... The global patient safety ... of delivery, end-user, and geography. Patient safety has ... globe. The field has developed significantly in the last decade and ...
(Date:3/28/2017)... "Chemotherapy Induced Neutropenia (CIN) – Market Insights, Epidemiology and Market Forecast-2023" ... of the Chemotherapy Induced Neutropenia for the seven major markets i.e., ... ( France , Germany , ... Japan , as well as rest of ... The Report covers the therapeutics market revenue, treatment practice ...
(Date:3/28/2017)...  Medeon Biodesign, Inc., a Taiwan ... announce that the Company led and successfully closed ... a San Jose, CA ... extremity applications.  The orthopedic extremity ... to procedure volume growth, lifestyle influences and favorable ...
Breaking Medicine Technology: